SPECTRUM BIOMEDICAL, LLC and OPTIMUM BIO, LLC agreed to acquire 31.38% stake in Liminatus Pharma, LLC from Ewon Comfortech Co., Ltd. (KOSDAQ:A088290) for KRW 25.7 billion on March 17, 2023. Liminatus Pharma has total assets of KRW 74.27 billion and KRW 47.57 billion. The Scheduled sale dates is of March 17, 2023.